Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;12(54):35484-35493.
doi: 10.1039/d2ra06306a. eCollection 2022 Dec 6.

Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles

Affiliations

Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles

Eleonora Colombo et al. RSC Adv. .

Abstract

Hetero-nanoparticles self-assembled from a conjugate bearing folic acid as the targeting agent, and another bearing paclitaxel as the active agent are reported. Hetero-nanoparticles containing varying percentages of folic acid conjugates are characterised, and their biological activity is determined.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Schematic representation of targeted hetero-NPs, with folic acid highlighted in detail – pteroic acid in red, l-glutamic acid in blue.
Fig. 2
Fig. 2. Chemical structure of paclitaxel (top, 1) and folic acid conjugates (bottom, 2).
Scheme 1
Scheme 1. Synthesis of conjugate 1. a: DIPEA, HATU, dry THF, rt, 18 h, 30%, b: EDC·HCl, DMAP, rt, 22 h, 52%.
Scheme 2
Scheme 2. Synthesis of linker-self-assembly inducer 12. a: Boc2O, NaOH/diox, rt, 20 h, quant.; b: 3, HATU, DIPEA, dry THF, rt, 23 h, 94%; c: TFA, dry CH2Cl2, 0 °C to rt, 20 h, quant.; d: 8, HATU, DIPEA, dry THF, rt, 21 h, 73%; e: TFA, dry CH2Cl2, 0 °C to rt, 18 h, 90%.
Scheme 3
Scheme 3. Retrosynthetic pathway for target folic acid conjugate 2.
Scheme 4
Scheme 4. Synthesis of l-glutamic acid Cα-TMSE ester 18. a: (1) CDI, dry CH2Cl2, 0 °C to rt, 1 h; (2) TMSEtOH, rt, 19 h, 54%; b: H2, Pd/C, dry EtOH, rt, 3 h, 91%; c: pTsOH·H2O, diox/H2O, 60 °C, 3 h, quant.
Scheme 5
Scheme 5. Synthesis of N-protected, C-activated pteroic acid 17. a: (1) CDI, dry DMSO, 50 °C, 5 h; (2) TMSEtOH, 50 °C, 21 h, 51%.
Scheme 6
Scheme 6. Synthesis of activated protected folic acid. a: MTBD, dry DMSO, rt, 21 h, 33%; b: NHS, EDC, dry DMF, rt, 19 h, 94%.
Scheme 7
Scheme 7. Synthesis of folic acid conjugate 2. a: TEA, dry DMSO, rt, 5 h, 40%; b: (1) 1 M TBAF, dry DMSO, rt, 19 h; (2) 0.2 M NaOAc, dry DMSO, rt, 10 min, 66%.
Fig. 3
Fig. 3. TEM micrographs of nanoparticles formed by self-assembly hNP2. All samples were stained with uranyl acetate solution.
Fig. 4
Fig. 4. Cell viability for HeLa cells treated for 72 h with hNP1 to hNP4 at equivalent PTX concentrations (400 nM to 50 μM), and with self-assembly inducer 5 and free PTX 6 (312.5 nM to 5 μM) as control. Reported values are the mean ± SD (n = 3) normalized against untreated sample.

References

    1. Shen S. Wu Y. Liu Y. Wu D. Int. J. Nanomed. 2017;12:4085–4109. - PMC - PubMed
    1. Wang Y. Santos A. Evdokiou A. Losic D. J. Mater. Chem. B. 2015;3:7153–7172. - PubMed
    1. Zhang Y. Fang F. Li L. Zhang J. ACS Biomater. Sci. Eng. 2020;6:4816–4833. - PubMed
    1. Borrelli S. Christodoulou M. S. Ficarra I. Silvani A. Cappelletti G. Cartelli D. Damia G. Ricci F. Zucchetti M. Dosio F. Passarella D. Eur. J. Med. Chem. 2014;85:179–190. - PubMed
    1. Ntungwe E. Domínguez-Martín E. M. Bangay G. Garcia C. Guerreiro I. Colombo E. Saraiva L. Díaz-Lanza A. M. Rosatella A. Alves M. M. Reis C. P. Passarella D. Rijo P. Int. J. Mol. Sci. 2021;22:10210. - PMC - PubMed